Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Logicbio Therapeutics, Inc. (LOGC) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Logicbio Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1664106.
Total stock buying since 2018: $56,977,784.
Total stock sales since 2018: $4,665,500.
Total stock option exercises since 2018: $54,750.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 0 | $0 | 0 | $0 | 5,939 | $0 |
| 2021 | 0 | $0 | 11,986 | $66,654 | 53,047 | $0 |
| 2020 | 2,962,964 | $17,777,784 | 597,587 | $4,598,846 | 2,513 | $0 |
| 2019 | 0 | $0 | 0 | $0 | 75,000 | $54,750 |
| 2018 | 3,920,000 | $39,200,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-01 | 0 | $0 | 0 | $0 | 5,939 | $0 |
| 2021-08 | 0 | $0 | 1,467 | $6,381 | 4,798 | $0 |
| 2021-04 | 0 | $0 | 10,519 | $60,273 | 32,774 | $0 |
| 2021-01 | 0 | $0 | 0 | $0 | 15,475 | $0 |
| 2020-12 | 0 | $0 | 0 | $0 | 2,513 | $0 |
| 2020-10 | 2,962,964 | $17,777,784 | 0 | $0 | 0 | $0 |
| 2020-09 | 0 | $0 | 486,317 | $3,588,772 | 0 | $0 |
| 2020-08 | 0 | $0 | 1,494 | $13,125 | 0 | $0 |
| 2020-07 | 0 | $0 | 109,776 | $996,949 | 0 | $0 |
| 2019-08 | 0 | $0 | 0 | $0 | 75,000 | $54,750 |
| 2018-10 | 3,920,000 | $39,200,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-01-11 | Jones Cecilia (Chief Financial Officer) | Option Ex | 5,939 | .00 | 0 |
| 2021-08-09 | Gruskin Daniel (Chief Medical Officer) | Sale | 1,467 | 4.35 | 6,381 |
| 2021-08-06 | Gruskin Daniel (Chief Medical Officer) | Option Ex | 4,798 | .00 | 0 |
| 2021-04-16 | Chiang Kyle (Chief Operating Officer) | Sale | 2,977 | 5.73 | 17,058 |
| 2021-04-16 | Chereau Frederic (President and Chief Executive) | Sale | 7,542 | 5.73 | 43,215 |
| 2021-04-15 | Chiang Kyle (Chief Operating Officer) | Option Ex | 9,360 | .00 | 0 |
| 2021-04-15 | Chereau Frederic (President and Chief Executive) | Option Ex | 23,414 | .00 | 0 |
| 2021-01-01 | Kay Mark A (Director) | Option Ex | 2,199 | .00 | 0 |
| 2021-01-01 | Chen Leon (Director) | Option Ex | 3,298 | .00 | 0 |
| 2021-01-01 | Enyedy Mark J (Director) | Option Ex | 2,921 | .00 | 0 |
| 2021-01-01 | Wyzga Michael S (Director) | Option Ex | 3,141 | .00 | 0 |
| 2021-01-01 | Moscicki Richard A (Director) | Option Ex | 3,916 | .00 | 0 |
| 2020-12-10 | O'connell Daniel P (Director) | Option Ex | 2,513 | .00 | 0 |
| 2020-10-01 | Orbimed Genesis Gp Llc | Buy | 1,481,482 | 6.00 | 8,888,892 |
| 2020-10-01 | Chimovits Erez | Buy | 1,481,482 | 6.00 | 8,888,892 |
| 2020-09-28 | Arix Bioscience Holdings Ltd (10% Owner) | Sale | 273,584 | 7.54 | 2,062,002 |
| 2020-09-25 | Arix Bioscience Holdings Ltd (10% Owner) | Sale | 174,219 | 7.08 | 1,232,947 |
| 2020-09-24 | Arix Bioscience Holdings Ltd (10% Owner) | Sale | 38,514 | 7.63 | 293,823 |
| 2020-08-13 | Arix Bioscience Holdings Ltd (10% Owner) | Sale | 159 | 8.75 | 1,391 |
| 2020-08-12 | Arix Bioscience Holdings Ltd (10% Owner) | Sale | 1,335 | 8.79 | 11,734 |
| 2020-07-29 | Arix Bioscience Holdings Ltd (10% Owner) | Sale | 2,709 | 8.78 | 23,787 |
| 2020-07-22 | Arix Bioscience Holdings Ltd (10% Owner) | Sale | 22,651 | 9.00 | 203,949 |
| 2020-07-20 | Arix Bioscience Holdings Ltd (10% Owner) | Sale | 36,983 | 9.25 | 342,055 |
| 2020-07-17 | Arix Bioscience Holdings Ltd (10% Owner) | Sale | 31,101 | 9.24 | 287,373 |
| 2020-07-16 | Arix Bioscience Holdings Ltd (10% Owner) | Sale | 16,332 | 8.56 | 139,785 |
| 2019-08-27 | Wilton Thomas (Chief Business Officer) | Option Ex | 75,000 | .73 | 54,750 |
| 2018-10-23 | Arix Bioscience Holdings Ltd (10% Owner) | Buy | 700,000 | 10.00 | 7,000,000 |
| 2018-10-23 | O'connell Daniel P (Director) | Buy | 700,000 | 10.00 | 7,000,000 |
| 2018-10-23 | Ioannidou Sofia (Director) | Buy | 420,000 | 10.00 | 4,200,000 |
| 2018-10-23 | Chimovits Erez (Director) | Buy | 490,000 | 10.00 | 4,900,000 |
| 2018-10-23 | Orbimed Israel Gp Ii, L.p. (Director) | Buy | 1,190,000 | 10.00 | 11,900,000 |
| 2018-10-23 | Kariv Tomer (Director) | Buy | 420,000 | 10.00 | 4,200,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of LOGC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Logicbio Therapeutics, Inc. (symbol LOGC, CIK number 1664106) see the Securities and Exchange Commission (SEC) website.